SCHEMBL6539764

SCHEMBL6539764

COc1ccc(C(C(=O)c2ccc(OCc3ccccc3)cc2)N2C(=O)c3ccccc3C2=O)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.50
PABPC1 P11940 1/20 0.50
KMT2A Q03164 1/20 0.50
ACACB O00763 2/20 0.44
ACACA Q13085 2/20 0.44
POLB P06746 2/20 0.43
MAOB P27338 2/20 0.43
NR4A1 P22736 1/20 0.42
NR4A2 P43354 1/20 0.42
NR4A3 Q92570 1/20 0.42
FFAR1 O14842 1/20 0.41
TNF P01375 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PARP10 Q53GL7 1/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
SRD5A2 P31213 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538976 0.88 POLB (0.50) POLBMAOBNR4A1NR4A2NR4A3
SCHEMBL6206366 0.81 MEN1 (0.56) MEN1PABPC1KMT2AACACBACACA
Hydrochloric Acid SCHEMBL6207662 0.80 MEN1 (0.55) MEN1PABPC1KMT2AACACBACACA
SCHEMBL6231187 0.77 MEN1 (0.55) MEN1PABPC1KMT2AACACBACACA
SCHEMBL6208425 0.77 MEN1 (0.56) MEN1PABPC1KMT2AACACBACACA
SCHEMBL6540586 0.77 MEN1 (0.54) MEN1PABPC1KMT2AACACBACACA
SCHEMBL6539741 0.77 TNF (0.47) POLBMAOBNR4A1NR4A2NR4A3
SCHEMBL6540380 0.76 MEN1 (0.52) MEN1PABPC1KMT2AACACBACACA
SCHEMBL6539604 0.75 MEN1 (0.53) MEN1PABPC1KMT2AACACBACACA
SCHEMBL16322642 0.74 GRM5 (0.53) MEN1KMT2APOLBMAOBALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 MEN1 4420/4885PABPC1 2765/4885KMT2A 3081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.